| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc85a8cdec567180059f043ff74ea935 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-515 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y601-01002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0008 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-53 |
| filingDate |
2006-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d32cfbc3403062b8c0880cd32b9d189
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e50ce9704d78d232409d0a5a4077800
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e588b6e588ce23ce588dd23bf1d1905d |
| publicationDate |
2010-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2401124-C2 |
| titleOfInvention |
Revascularisation of ischemic retinal tissue and screening technique |
| abstract |
FIELD: medicine. ^ SUBSTANCE: favourable physiological revascularisation of ischemic retinal tissue is stimulated by the introduction of therapeutically effective amount of an angiostatic fragment of tryptophanyl-tRNA synthetase (TrpRS). ^ EFFECT: invention provides both inhibition of pathologic neovascularisation, and effective stimulation of physiological revascularisation of ischemic retina ensured by the selection of specified angiostatic agent. ^ 5 cl, 4 ex, 8 dwg |
| priorityDate |
2005-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |